Device Trial Radar · NCT00744861
Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery
Last checked: Nov 20, 2026Latest source record: Apr 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
328
Actual
Start
Sep 2008
Primary completion
May 2012
Study completion May 2012
Sponsor
- Lead sponsor
- Bioventus LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 1, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 81 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Adjunct therapy for increasing posterolateral fusion success following single level posterior instrumented lumbar surgery.
Conditions
- Lumbar Degenerative Disc Disease
Interventions
Exospine shamDevice
Inactive Exospine LIPUS device (dual transducers)
ExospineDevice
Active Exospine LIPUS device (dual transducers)
Exogen 4000+Device
Active Exogen LIPUS device (single transducer)
Exogen 4000+ shamDevice
Inactive Exogen 4000+ LIPUS device (single transducer)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Posterolateral Fusion Success at the Treated LevelTime frame: 12 months post treatment start
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.